sulfaphenazole has been researched along with Anemia, Hemolytic in 1 studies
Sulfaphenazole: A sulfonilamide anti-infective agent.
sulfaphenazole : A sulfonamide that is sulfanilamide in which the sulfonamide nitrogen is substituted by a 1-phenyl-1H-pyrazol-5-yl group. It is a selective inhibitor of cytochrome P450 (CYP) 2C9 isozyme, and antibacterial agent.
Anemia, Hemolytic: A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de LEEUW, N | 1 |
| SHAPIRO, L | 1 |
| LOWENSTEIN, L | 1 |
1 other study available for sulfaphenazole and Anemia, Hemolytic
| Article | Year |
|---|---|
Drug-induced hemolytic anemia.
Topics: Analgesics; Analgesics, Non-Narcotic; Anemia; Anemia, Hemolytic; Antipyretics; Monoamine Oxidase Inh | 1963 |